These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21997573)

  • 1. Assessment of respiratory physiology of C57BL/6 mice following bleomycin administration using barometric plethysmography.
    Milton PL; Dickinson H; Jenkin G; Lim R
    Respiration; 2012; 83(3):253-66. PubMed ID: 21997573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
    Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
    Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
    Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
    J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).
    Molina V; Haj-Yahia S; Solodeev I; Levy Y; Blank M; Shoenfeld Y
    Autoimmunity; 2006 Dec; 39(8):711-7. PubMed ID: 17178568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
    Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
    Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
    Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
    Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats.
    Zhou XM; Zhang GC; Li JX; Hou J
    J Ethnopharmacol; 2007 May; 111(2):255-64. PubMed ID: 17188826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor NRF2 protects against pulmonary fibrosis.
    Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
    FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
    Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
    Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
    Nici L; Santos-Moore A; Kuhn C; Calabresi P
    Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
    Gao JM; Lu B
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
    Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
    Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice.
    Chen Y; Wang X; Weng D; Tian L; Lv L; Tao S; Chen J
    Exp Toxicol Pathol; 2009 Jan; 61(1):59-65. PubMed ID: 18579356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.
    Harrison JH; Lazo JS
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1185-94. PubMed ID: 2447265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis.
    Keane MP; Belperio JA; Arenberg DA; Burdick MD; Xu ZJ; Xue YY; Strieter RM
    J Immunol; 1999 Nov; 163(10):5686-92. PubMed ID: 10553099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of hochu-ekki-to, a Japanese herbal medicine, on bleomycin-induced lung injury in mice.
    Tajima S; Bando M; Yamasawa H; Ohno S; Moriyama H; Terada M; Takada T; Suzuki E; Gejyo F; Sugiyama Y
    Respirology; 2007 Nov; 12(6):814-22. PubMed ID: 17986108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse.
    Haston CK; Amos CI; King TM; Travis EL
    Cancer Res; 1996 Jun; 56(11):2596-601. PubMed ID: 8653703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.